1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow depelestat: new trials by email Literature Review of depelestat trials Research Report on depelestat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC Biospecimen Collection, Breast Biopsy Procedure, Carboplatin - Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | Phase 2 | Recruiting | Vandana Abramson | 51 | 2025-09-09 | 2025-10-30 |
| Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients EPI-hNE4, Placebo - Fibrosis, Lung Disease | Phase 2 | Completed | Debiopharm International SA | 84 | 2006-07-01 | 2008-06-24 |
Fibrosis (1) · Inflammation (1) · Lung Diseases (1) · Pulmonary Fibrosis (1) · Respiration Disorders (1) · Respiratory Distress Syndrome (1) · Triple Negative Breast Neoplasms (1)
Debiopharm International SA (1) · Vandana Abramson (1)
France (1) · Italy (1) · Spain (1) · Tunisia (1) · United States (1)
P30CA068485 (1)